Cancer and Virus Leads by HTS, Chemical Design and SEA Data Mining

Author(s): Pahk Thepchatri, Jaeki Min, Thota Ganesh, Yuhong Du, Iestyn Lewis, Serdar Kurtkaya, Andrew Prussia, Lian Li, Blossom Sneed, Richard K. Plemper, Haian Fu, Dennis C. Liotta, James P. Snyder, Raymond Dingledine, Aiming Sun

Journal Name: Current Topics in Medicinal Chemistry

Volume 9 , Issue 13 , 2009

Become EABM
Become Reviewer


A variety of medicinal chemistry approaches can be used for the identification of hits, generation of leads and to accelerate the development of drug candidates. The Emory Chemical and Biology Discovery Center (ECBDC) has been an active participant in the NIHs high-throughput screening (HTS) endeavor to identify potent small molecule probes for poorly studied proteins. Several of Emorys projects relate to cancer or virual infection. We have chosen three successful examples including discovery of potent measles virus RNA-dependent RNA polymerase inhibitors, development of Heat Shock Protein 90 (Hsp90) blockers and identification of angiogenesis inhibitors using transgenic Zebrafish as a HTS model. In parallel with HTS, a unique component of the Emory virtual screening (VS) effort, namely, substructure enrichment analysis (SEA) program has been utilized in several cases.

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2009
Page: [1159 - 1171]
Pages: 13
DOI: 10.2174/156802609789753581
Price: $65

Article Metrics

PDF: 3